Minnetonka, MNNCT06257355Now EnrollingIRB Ready

Corneal Scar Clinical Trial in Minnetonka, MN

Access cutting-edge corneal scar treatment through this clinical trial at a research site in Minnetonka. Study-provided care at no cost to qualified participants.

Sponsored by Claris Biotherapeutics, Inc.

Quick Self-Assessment

See if you qualify for this Minnetonka location

Preparing your pre-screening questions…

Expert Care in Minnetonka

Access corneal scar specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related corneal scar treatment provided free

Apply for This Minnetonka Location

Check if you qualify for this corneal scar clinical trial in Minnetonka, MN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Minnetonka

    Convenient for MN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Minnetonka site if eligible
  4. 4Begin participation

About This Corneal Scar Study in Minnetonka

This study will enroll subjects with recently formed corneal scars that resulted from a corneal insult presenting and diagnosed within the past approximately 30 days and not less than approximately 7 days. All subjects will be assigned to CSB-001 investigational treatment on Day 1. All subjects will dose with CSB-001 four times daily or three times daily starting on Day 1 and continue until Day 14. Subjects with a resolved scar at Day 7 will discontinue dosing and return to the clinic on Day 14. Subjects will return on Days 21, 28, 56, and Month 3 for safety and efficacy assessments.

Sponsor: Claris Biotherapeutics, Inc.

Who Can Participate

Inclusion Criteria

Centrally or paracentrally located scar approximately ≤5 mm and ≥2 mm in the greatest diameter and with a portion of the scar within approximately 3.5 mm of the optical center of the cornea assessed at Screening and confirmed at Baseline, and subject reports ability to detect any effect of scar on any element of vision.
Eye with a recent corneal insult approximately ≤30 days and ≥7 days from the Screening Visit.
Corneal insult includes but is not limited to mechanical / chemical / thermal injury, bacterial keratitis, PRK, and contact lens related ulcer.
Eye with observed rate of epithelialization that in the investigator's opinion does not demonstrate clinical characteristics of a slow healing (persistent defect) cornea.
Subjects must have the ability and willingness to comply with study procedures.

Exclusion Criteria

Corneal scar that encompasses more than approximately 50% of the depth of the remaining stroma as guided by ASOCT image at the Screening Visit.
Maximum scar diameter greater than approximately 5 mm without prior approval by the Sponsor based on Screening Visit images.
No portion of the scar is within the approximate 3.5 mm of the optical center of the cornea based on Screening Visit images.
Any active ocular infection in the opinion of the investigator (bacterial, viral, fungal, or protozoal) at the Screening or Day 1 Visits. Subjects with an active bacterial infection at the Screening or Day 1 Visit in the opinion of the investigator may be rescheduled to reassess the status of the infection and continue in the study if infection is deemed not active.
Ocular surgery planned during the study treatment period.
Presence or history of any ocular or systemic disorder, condition or procedure that might hinder the efficacy of the study treatment or its evaluation, could possibly interfere with the interpretation of study results, or could be judged by the investigator to be incompatible with the study visit schedule or conduct. Note: Other inclusion/exclusion criteria apply.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Minnetonka?

Yes, this clinical trial (NCT06257355) has an active research site in Minnetonka, MN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Corneal Scar Treatment Options in Minnetonka, MN

If you're searching for corneal scar treatment options in Minnetonka, MN, this clinical trial (NCT06257355) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Minnetonka research site is actively enrolling participants for this clinical trial. You'll receive care from experienced corneal scar specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Ready to Join in Minnetonka?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Minnetonka, MN